This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Queen's University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $742,052
A Randomized Phase III Multicentre Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
CIHR · 2024 · Principal investigator
A Randomized Phase III Multicentre Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula
Principal investigators: O'Callaghan, Christopher J; Karanicolas, Paul J
Keywords: Distal Pancreatectomy; Lanreotide; Pancreatic Cancer; Phase Iii; Postoperative Pancreatic Fistula (Popf); Quality Of Life; Rct; Somastatin Analogues (Ssas); Surgery
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.